Stocks and Investing Stocks and Investing
Mon, December 4, 2017
[ 12:00 AM ] - WOPRAI
Joe Reagor Initiated (USAS) at Strong Buy and Held Target at $5.75 on, Dec 4th, 2017
[ 12:00 AM ] - WOPRAI
Greg Melich Initiated (AAP) at Hold on, Dec 4th, 2017
[ 12:00 AM ] - WOPRAI
Greg Melich Initiated (AZO) at Hold on, Dec 4th, 2017
[ 12:00 AM ] - WOPRAI
Gabe Hilmoe Upgraded (BDN) to Buy on, Dec 4th, 2017
[ 12:00 AM ] - WOPRAI
Greg Melich Initiated (BBY) at Strong Sell on, Dec 4th, 2017
[ 12:00 AM ] - WOPRAI
Steve Sakwa Upgraded (AMH) to Buy on, Dec 4th, 2017
[ 12:00 AM ] - WOPRAI
Michael Nannizzi Initiated (ALL) at Hold and Held Target at $104 on, Dec 4th, 2017
[ 12:00 AM ] - WOPRAI
Greg Melich Initiated (AMZN) at Strong Buy on, Dec 4th, 2017
[ 12:00 AM ] - WOPRAI
Greg Melich Initiated (AN) at Hold on, Dec 4th, 2017
[ 12:00 AM ] - WOPRAI
Yaron Kinar Initiated (AON) at Hold and Held Target at $149 on, Dec 4th, 2017
[ 12:00 AM ] - WOPRAI
Glen Santangelo Initiated (CAH) at Hold and Held Target at $64 on, Dec 4th, 2017
[ 12:00 AM ] - WOPRAI
Yaron Kinar Initiated (CB) at Strong Buy and Held Target at $167 on, Dec 4th, 2017
[ 12:00 AM ] - WOPRAI
Michael Nannizzi Initiated (AIG) at Hold and Held Target at $61 on, Dec 4th, 2017
Fri, December 1, 2017
[ 12:00 AM ] - WOPRAI
Jerry Revich Upgraded (AGCO) to Strong Buy on, Dec 1st, 2017
[ 12:00 AM ] - WOPRAI
Joel Houck Initiated (AGNC) at Hold and Held Target at $19 on, Dec 1st, 2017
[ 12:00 AM ] - WOPRAI
Donald Fandetti Initiated (ALLY) at Buy and Held Target at $30 on, Dec 1st, 2017
[ 12:00 AM ] - WOPRAI
Tobey Sommer Initiated (BAH) at Strong Buy and Held Target at $47 on, Dec 1st, 2017
[ 12:00 AM ] - WOPRAI
Kevin McCarthy Downgraded (AXTA) to Hold on, Dec 1st, 2017
[ 12:00 AM ] - WOPRAI
Christian Schwab Initiated (ACMR) at Strong Buy and Held Target at $3.33 on, Dec 1st, 2017
[ 12:00 AM ] - WOPRAI
Carol Werther Initiated (SMMT) at Strong Buy and Held Target at $16 on, Dec 1st, 2017
[ 12:00 AM ] - WOPRAI
Nathan Isbee Initiated (BRX) at Hold and Held Target at $19 on, Dec 1st, 2017
[ 12:00 AM ] - WOPRAI
William Stein Downgraded (ST) to Hold on, Dec 1st, 2017
[ 12:00 AM ] - WOPRAI
Debjit Chattopadhyay Initiated (SRPT) at Strong Buy and Held Target at $75 on, Dec 1st, 2017
[ 12:00 AM ] - WOPRAI
Madhu Kumar Initiated (TGTX) at Strong Buy and Held Target at $22 on, Dec 1st, 2017
Thu, November 30, 2017
[ 12:00 AM ] - WOPRAI
Paul Coster Upgraded (TPIC) to Buy on, Nov 30th, 2017
[ 12:00 AM ] - WOPRAI
Chris Kotowski Initiated (WHF) at Buy and Held Target at $15 on, Nov 30th, 2017
[ 12:00 AM ] - WOPRAI
Sean Lavin Upgraded (BSX) to Strong Buy on, Nov 30th, 2017
[ 12:00 AM ] - WOPRAI
Raghuram Selvaraju Downgraded (XRAY) to Hold on, Nov 30th, 2017
[ 12:00 AM ] - WOPRAI
Paul Forward Initiated (CEIX) at Strong Buy and Held Target at $32 on, Nov 30th, 2017
[ 12:00 AM ] - WOPRAI
Jason McCarthy Maintained (BLUE) at Strong Buy with Increased Target to $200 on, Nov 30th, 2017

Jason McCarthy Maintained (BLUE) at Strong Buy with Increased Target to $200 on, Nov 30th, 2017


Published on 2024-10-26 01:16:53 - WOPRAI, Jason McCarthy
  Print publication without navigation


Jason McCarthy of Maxim Group, Maintained "bluebird bio, Inc." (BLUE) at Strong Buy with Increased Target from $170 to $200 on, Nov 30th, 2017.

Jason has made no other calls on BLUE in the last 4 months.



There are 6 other peers that have a rating on BLUE. Out of the 6 peers that are also analyzing BLUE, 3 agree with Jason's Rating of Hold. Following are those relevant analyst calls for the last 4 months

  • Josh Schimmer of "Evercore ISI Group" Downgraded from Buy to Hold on, Monday, November 6th, 2017
  • Matthew Harrison of "Morgan Stanley" Upgraded from Sell to Hold on, Friday, November 3rd, 2017
  • Biren Amin of "Jefferies" Downgraded from Strong Buy to Hold on, Wednesday, October 11th, 2017


These are the ratings of the 3 analyists that currently disagree with Jason

  • Dane Leone of "BTIG" Upgraded from Hold to Strong Buy on, Thursday, November 2nd, 2017
  • Gena Wang of "Barclays" Maintained at Buy with Increased Target to $162 on, Thursday, November 2nd, 2017
  • Matthew Luchini of "BMO Capital" Maintained at Buy with Increased Target to $162 on, Monday, October 30th, 2017
Contributing Sources